BACK TO VIRTUAL BOOTH
We provide easy-to-use multiplex molecular diagnostic platforms with superior sensitivity and specificity focused on sectors of Obstetrics-Gynaecology, Oncology, and Infectious Diseases based on our original patented technologies. We offer a complete solution for SARS-CoV-2 (COVID-19) detection from sample collection/transport, nucleic acid preparation to molecular detection authorized by the US FDA, and the Korean government. Also, you can find the first real-time PCR-based Non-invasive Prenatal Test (NIPT) and Microsatellite Instability (MSI) Detection Kit cleared by the Korean government.